1. Home
  2. FFBC vs SUPN Comparison

FFBC vs SUPN Comparison

Compare FFBC & SUPN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo First Financial Bancorp.

FFBC

First Financial Bancorp.

HOLD

Current Price

$26.84

Market Cap

2.3B

Sector

Finance

ML Signal

HOLD

Logo Supernus Pharmaceuticals Inc.

SUPN

Supernus Pharmaceuticals Inc.

HOLD

Current Price

$47.22

Market Cap

2.6B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
FFBC
SUPN
Founded
1863
2005
Country
United States
United States
Employees
N/A
N/A
Industry
Major Banks
Biotechnology: Pharmaceutical Preparations
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
2.3B
2.6B
IPO Year
N/A
2012

Fundamental Metrics

Financial Performance
Metric
FFBC
SUPN
Price
$26.84
$47.22
Analyst Decision
Buy
Strong Buy
Analyst Count
7
4
Target Price
$28.83
$63.25
AVG Volume (30 Days)
610.0K
664.8K
Earning Date
01-22-2026
11-04-2025
Dividend Yield
3.73%
N/A
EPS Growth
16.38
N/A
EPS
2.70
N/A
Revenue
$815,886,000.00
$681,539,000.00
Revenue This Year
$22.79
$8.32
Revenue Next Year
$19.78
$23.36
P/E Ratio
$9.94
N/A
Revenue Growth
7.05
4.54
52 Week Low
$21.10
$29.16
52 Week High
$30.17
$57.65

Technical Indicators

Market Signals
Indicator
FFBC
SUPN
Relative Strength Index (RSI) 72.50 53.47
Support Level $25.96 $45.36
Resistance Level $27.21 $47.26
Average True Range (ATR) 0.51 1.23
MACD 0.23 0.36
Stochastic Oscillator 89.70 92.10

Price Performance

Historical Comparison
FFBC
SUPN

About FFBC First Financial Bancorp.

First Financial Bancorp is a mid-sized, regional bank holding company. It engages in the business of commercial banking and other banking and banking-related activities through its subsidiary. The range of banking services provided to individuals and businesses includes commercial lending, real estate lending and consumer financing. Real estate loans are loans secured by a mortgage lien on the real property of the borrower, which may either be residential property or commercial property. In addition, it offers deposit products that include interest-bearing and noninterest-bearing accounts, time deposits and cash management services for commercial customers. A full range of trust and wealth management services is also provided through First Financial's Wealth Management line of business.

About SUPN Supernus Pharmaceuticals Inc.

Supernus Pharmaceuticals Inc is a specialty pharmaceutical company. The company is engaged in developing and commercializing products for the treatment of central nervous system diseases, including neurological and psychiatric disorders. Its diverse neuroscience portfolio includes approved treatments for epilepsy, migraine, attention-deficit hyperactivity disorder (ADHD), hypomobility in Parkinson's Disease (PD), cervical dystonia, chronic sialorrhea, dyskinesia in PD patients receiving levodopa-based therapy, and drug-induced extrapyramidal reactions in adult patients. The company's products include Trokendi XR, Oxtellar XR, Qelbree, APOKYN, XADAGO, MYOBLOC, GOCOVRI, and Osmolex ER.

Share on Social Networks: